leisure time -WSS

leisure time

author：leisure time 2025-09-06 01:57:39 - browse：9

Photo illustration of Fyodor Urnov surrounded by DNA strands. -- health coverage from STAT — Christine Kao/STAT

Researchers attending gene therapy meetings over the past couple years were liable to bump into a svelte, graying scientist explaining in emphatic, Russian-inflected English that the U.S. was wasting the grand potential of CRISPR gene editing.

Fyodor Urnov, the scientist in question, estimates he gave the talk 30 to 40 times: to fellow researchers, pharma executives, Food and Drug Administration officials, congressional staff, journalists, patient advocates. “Anyone who would listen,” he says.

The problem was one of scale. Sure, for-profit companies were developing cures for a small handful of genetic diseases, such as sickle cell disease. But there were hundreds of devastating conditions that CRISPR might be able to cure but that no entity was seriously working on.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： As demand for Covid shots wanes, Moderna seeks its next success
Next article： Election results set back Medicaid expansion plans

WSS

Sweden knocks USA out of World Cup in penalty kicks

Paxlovid rebound happens. Why and to whom are still a mystery

The Readout: Abbvie and Humira, CRISPR in utero, Annovis Bio

Doctors push to include dialysis machines in emergency stockpile

Slovenia has suffered its worst

Alabama hospital puts IVF treatments on hold

focus

leisure time

focus

Moonlake's readout produced a cash windfall. Risks remain

How CRISPR works, explained in two minutes

FDA approval of Sarepta Duchenne genetic therapy gives me hope

NIH study of ME/CFS points to clear biological hallmarks

Novavax promises a turnaround & Lilly roils the obesity market

The Harvard botanist who searched for psychedelics in the Amazon

After affirmative action ruling, medical educators look to 'holistic review'

Annovis Bio delivers candor, but not confidence, on Parkinson’s study

Jerome Adams on the need for new antivirals for Covid

PBM reform efforts get punted in Congress

hotspot

NIH study of ME/CFS points to clear biological hallmarks

He's a Nobel laureate. Critics say he was misleading on Covid

Many breast cancer patients receive more radiation than needed

Severe weather updates: 1 million customers without power in 11 states as storms pummel East Coast

A new nitrogen execution bill also undermines medical licensing

Mexico finds 491 migrants being held at vacant lot, almost all are from Guatemala

leisure time

focus

hotspot

hotspot